In addition to genetic factors, environmental factors also play a role in the development of type 1 diabetes. Viral infections, such as enteroviruses, have been linked to triggering the immune response that leads to the destruction of beta cells. Other environmental factors being studied include early childhood diet, exposure to certain chemicals, and even the microbiome. Researchers are working to better understand how these environmental factors interact with genetic predisposition to cause type 1 diabetes.
Genetics and Type 1 Risk
While most people with type 1 diabetes do not have a family history of the disease, genetics can predispose individuals to it.
There are certain genes associated with a higher risk of developing diabetes, but an environmental trigger is needed for the disease to manifest.
Development of Type 1 Diabetes
Type 1 diabetes is an autoimmune disease where the immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas. This gradual destruction of beta cells leads to a decrease in insulin production, resulting in high levels of glucose in the blood.
While type 1 diabetes can develop at any age, it is rare in infants younger than six months old. However, it most commonly appears in children, adolescents, and young adults. The exact cause of type 1 diabetes is still unknown, but it is believed to be a combination of genetic predisposition and environmental factors.
Lifestyle and Type 1 Diabetes
Type 1 diabetes is an autoimmune condition and is not linked to diet or levels of physical activity.
Support for Living with Type 1 Diabetes
Guides are available to offer information and assistance in managing type 1 diabetes.
Type 1 diabetes leads to high blood sugar levels due to reduced insulin production by beta cells in the pancreas.
Symptoms may include increased urination, excessive thirst, fatigue, blurry vision, numbness in extremities, and weight loss.
Complications could include diabetic ketoacidosis, damage to organs and tissues, as well as a higher risk of heart attacks and strokes.
It is important for individuals with type 1 diabetes to monitor their blood sugar levels regularly, take insulin as prescribed, follow a healthy diet, engage in regular physical activity, and attend regular check-ups with healthcare providers.
Support groups and online communities can also provide valuable support and information for individuals living with type 1 diabetes.
Incidence and Prevalence
Annually, 10-20 out of every 100,000 people in the United States develop type 1 diabetes. The incidence rate varies globally.
Type 1 diabetes accounts for 5-10% of all diabetes cases worldwide.
HLA genes, also known as human leukocyte antigen genes, play a crucial role in the immune system by distinguishing between the body’s own cells and foreign invaders. Specific variations in the HLA genes have been linked to an increased risk of developing type 1 diabetes, an autoimmune disease where the immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas.
Studies have shown that individuals with certain HLA gene variants, such as HLA-DR3 and HLA-DR4, have a higher susceptibility to developing type 1 diabetes. These gene variants influence the immune system’s ability to recognize beta cells as “self,” leading to the destruction of these vital cells and resulting in insulin deficiency.
Understanding the role of HLA genes in type 1 diabetes can provide valuable insights into the mechanisms underlying the disease and may help in the development of targeted therapies or preventive strategies. Further research on the interactions between HLA genes and the immune system could lead to improved diagnostic tools and treatment options for individuals with type 1 diabetes.
Familial Inheritance
Type 1 diabetes risk can run in families, although the exact inheritance pattern is not clear.
Differences in Type 1 and Type 2 Diabetes
Both types of diabetes involve a combination of genetic predisposition and environmental factors.
Even identical twins may not both develop diabetes, indicating that genes alone are not the sole determinant.
Risk Factors and Triggers
Risk factors for type 1 diabetes require contributions from both parents. Environmental aspects like viruses and diet are under investigation.
Some factors may be more common in white populations, while cold weather and early dietary habits might also play a role in triggering diabetes.
For many individuals, the development of type 1 diabetes is a gradual process. Studies on relatives of diabetes patients have shown that most people who later develop diabetes had harmful autoantibodies in their blood for several years before diagnosis.
Risk for Your Child
If a man has type 1 diabetes, the child’s risk is 1 in 17. If a woman with diabetes had a child before the age of 25, the risk is 1 in 25; after 25, the risk is 1 in 100. The risk increases if diabetes developed before the age of 11, and having both parents with type 1 diabetes raises the risk to 1 in 4.
About 1 in 7 individuals with type 1 diabetes also have type 2 polyglandular autoimmune syndrome, which raises the child’s risk to 1 in 2. Genetic factors play a role, with certain genes increasing the risk in different ethnic groups.
Antibody tests can determine diabetes risk in children with diabetic siblings. These tests measure specific antibodies in the blood indicating a higher risk of developing type 1 diabetes.
If you suspect your child has diabetes, consult a doctor. Family members of diabetes patients may qualify for free risk screening through the TrialNet Pathway to Prevention Study, which can identify diabetes risk years before symptoms appear.
Is type 2 diabetes genetic?
Type 2 diabetes is more influenced by family history, lifestyle, and environmental factors. Genes do play a role, but lifestyle choices such as diet and exercise also impact diabetes development.
Individuals with a family history of type 2 diabetes can delay or prevent the disease through healthy habits. Encouraging children to eat healthily, exercise, and maintain a healthy weight can reduce their risk of type 2 diabetes.
Risk for Your Child
Children of parents with type 2 diabetes have an increased risk due to a combination of genetic and lifestyle factors. However, making healthy choices regarding food, physical activity, and weight can help prevent or delay type 2 diabetes in young individuals.
More Information on Genetics
The National Institutes of Health provides a free book on diabetes genetics, offering valuable insights into the genetics of type 1 and type 2 diabetes. This resource caters to healthcare professionals and individuals seeking to understand diabetes genetics.
Give Today and Change lives!
Sponsorship from the American Diabetes Association contributes to research advancements and resources for individuals combatting diabetes.
First published in April 2015.
Abstract
Type 1 diabetes is an autoimmune disease influenced by genetic and immunological factors. Specific genes and environmental triggers contribute to diabetes development, with autoantibodies serving as predictive markers for disease onset.
Environmental factors and viral infections may also play a role in diabetes development, while unique syndromes offer insights into the autoimmune mechanisms causing diabetes.
Keywords: Immunology, Genetics, Pathogenesis, Type 1 diabetes
1. Introduction
Genetic and immunological factors are involved in type 1 diabetes, with HLA genes and viral antigens affecting disease susceptibility. Seasonal patterns and autoimmune syndromes provide additional perspectives on the origins of diabetes.
Understanding autoantibodies and genetic mutations is crucial in comprehending type 1 diabetes, emphasizing the significance of T-cell responses in disease progression.
2. Association with other autoimmune diseases
Individuals with type 1 diabetes have a higher risk of developing autoimmune responses against other organs. Autoimmune thyroiditis and celiac disease are common conditions that may occur. Thyroid autoimmunity is prevalent in many individuals with type 1A diabetes, while approximately 10% of patients have transglutaminase autoantibodies. Specific genetic alleles contribute to susceptibility to both type 1 diabetes and celiac disease.
Type 1 diabetes can be found in individuals with polyglandular autoimmune disease, primarily type II, including adrenal insufficiency, autoimmune thyroid disease, and gonadal insufficiency. Rare syndromes like IPEX syndrome and APS-I syndrome shed light on the pathogenesis of type 1 diabetes.
The risk of T1DM is higher in family members of affected individuals, varying based on genes and family history. The HLA genes on chromosome 6 play a critical role in immune responses and antigen presentation to T cells.
Overall, genetic factors significantly contribute to the development of type 1 diabetes. The HLA complex on chromosome 6 is essential in immune responses and antigen presentation.
Immunologically mediated diseases, including specific endocrine syndromes, are genetically linked to distinct HLA molecules. Various hypotheses explain HLA-disease associations (Schwartz, 1996). Some HLA-associated diseases are correlated with gene variations encoding the class II molecule, such as T1DM. Other mechanisms beyond those mentioned above may be involved in HLA molecule-peptide interactions. The presentation of antigens by class II molecules relies on the amino-acid composition of their alpha and beta chains. Substitutions at crucial positions can impact susceptibility to type 1 diabetes (Khalil et al., 1990; Rowe et al., 1994).
More than 90% of T1DM patients carry either HLA-DR3, DQB1*0201 (DR3-DQ2) or – DR4, DQB1*0302 (DR4-DQ8). Around 30% of patients have both haplotypes (DR3/4 heterozygotes), which show the highest susceptibility. The DR3/4 heterozygote has a higher risk compared to homozygotes, attributed to specific DQ heterodimers present only in this genotype (Erlich et al., 2008). Studies indicate that additional loci contribute to T1DM risk.
HLA-DR2 prevalence is reduced in T1DM patients. The DQA1*0102/DQB1*0502/DRB1*1601 haplotype accounts for most of the susceptibility in DR2-associated T1DM cases. The effect of HLA alleles on T1DM susceptibility is summarized in Table 2.
Table 2
HLA Class II DR-DQ genotypes and T1DM Susceptibility in Caucasians
| HLA-DR | DQA1 | DQB1 | DRB1 | Risk of Developing the Condition |
|---|
| DR2 | 0102 | 0602 | 1501 | Category: Protective |
| DR3 | 0501 | 0201 | 0301 | Category: High Risk |
| DR4 | 0301 | 0302 | 0401 | Category: High Risk |
| DR4 | 0301 | 0302 | 0402 | Category: Predisposing |
| DR7 | 0201 | 0303 | 0701 | Category: Protective |
| DR6 | 0101 | 0503 | 1401 | Category: Protective |
Research conducted on the Filipino population by Mbunwe et al. in 2013 demonstrated a higher risk of diabetes associated with the HLA*24:02 allele, contrasting with the protective effect of the A*24:07 allele. The presence of A*24 has been identified as an independent predictor for the progression to T1DM in relatives of T1DM patients with antibodies. While other genetic markers may contribute to predictive algorithms, the precise role of A*24 as a genetic indicator remains to be fully understood.
### **HLA Class II Molecules in T1DM Pathogenesis**
Studies in NOD mice models have highlighted the role of HLA class II molecules in the pathogenesis of T1DM. Specific gene variants can offer protection against diabetes, and treatment with monoclonal antibodies has shown promise in diabetes prevention. The complex interplay between CD4+ T cell receptors, self-peptides, and MHC class II molecules is critical in autoimmune conditions, including T1DM.
Genes of the class II variety can influence susceptibility to T1DM by impacting antigen-binding sites. The maturation of TCR on T cells in the thymus involves both positive and negative selections based on interactions with MHC molecules and self-peptides. Each individual possesses a unique T-cell repertoire molded by thymic events.
Associations of HLA-DQ genes with T1DM have been linked to inefficient presentation of self-peptides, triggering autoimmune responses. Structural modifications in class II molecules can alter their antigen-presenting functions, significantly affecting disease susceptibility.
In conclusion, a comprehensive understanding of HLA class II molecules and TCR in the context of T1DM pathogenesis is crucial for the development of targeted therapeutic approaches for disease prevention.
### **Environmental Determinants in T1DM Development**
The development of T1DM is heavily influenced by environmental factors. Viral infections can trigger autoimmune reactions leading to diabetes, suggesting a role for the innate immune system in this process. Differences in intestinal microbiota composition hint at the involvement of the gastrointestinal system in the etiology of T1DM.
Longitudinal studies are essential to assess the impact of gut microbiota on the progression of T1DM. Identifying early patterns of gut microbiota and considering epigenetic influences are key factors in this regard.
### **Identification of Autoantigens in Pancreatic β-cells**
Understanding the role of autoantigens in pancreatic β-cells is crucial for unraveling the progression of autoimmune islet damage. Combining various humoral immunological markers can enhance the predictive value regarding the progression of T1DM.
Autoimmunity in T1DM evolves from initial activation to a chronic state, leading to the recognition of a higher number of islet autoantigens by T cells and autoantibodies, a phenomenon known as “epitope spreading.” Islet autoantibody responses against multiple autoantigens are associated with disease progression. Apart from insulin, other T1DM-related autoantigens include ICA69, IGRP, ChgA, insulin receptor, heat shock proteins, jun-B, CD38, peripherin, and GFAP.
The severity of T1DM symptoms intensifies over time, leading to the recognition of an increasing number of autoantigens by the immune system. The progression of epitope spreading begins in the pancreas targeting self-antigens, initiating a cascade where multiple self-antigens become targets for the immune system. Insulin is the initial target, followed by other components such as GAD65, IA-2, and ZnT8, creating various recognition epitopes through different antigen processing mechanisms. The immune system’s journey towards autoimmunity can be depicted as a tree with branches symbolizing self-antigens.
Key islet autoantigens linked to T1DM include Insulin, GAD65 and GAD67, ICA512(IA-2) and phogrin (IA-2β), ZnT8 (Slc30A8), ICA69, Chromogranin A, Carboxypeptidase H, Ganglioside GM2-1, Imogen 38 (38 kDa), Glima 38, Peripherin, and Heat-shock protein (Hsp60). Biochemical autoantibody assays are available for large-scale screening programs.
During immune system development, self-antigen-reacting lymphocytes are eliminated in the thymus and bone marrow. However, host molecules, especially proteins and nucleic acids, undergo constant modifications. Citrullination of arginine residues, catalyzed by peptidyl arginine deiminase (PAD), is a crucial post-translational modification in autoimmunity. Diseases like multiple sclerosis and rheumatoid arthritis (RA) feature citrullinated isoforms of myelin basic protein and fibrin. Detecting anti-citrullinated protein antibodies (ACPA) aids in the early diagnosis of RA.
The processing of molecules like insulin within β-cells generates peptides that are picked up by APCs to present islet peptides to T cells. Chromogranin A, an autoantigen in T1DM, stimulates CD4 + T cells through specific peptides. While insulin regulates metabolism, it also acts as a T1DM autoantigen. High levels of insulin autoantibodies in younger individuals signify a more severe disease course.
Autoantibodies against GAD and IA-2 serve as predictors of T1DM progression. Incubation studies with rat islets using [35S]-methionine identified GAD as a 64 kDa autoantigen in T1DM. IA-2 and phogrin, both neuroendocrine molecules, are involved in T1DM pathogenesis. Evaluating epitopes aids in detecting the presence of autoantibodies and assessing the risk of T1DM.
The combination of immunologic and metabolic strategies enables an accurate prediction of T1DM progression. Pancreatic histological examinations of T1DM patients reveal lymphocytic infiltration and β-cell mass loss, indicating the involvement of CTLs in β-cell destruction. CD8 + T cells and B lymphocytes play significant roles in β-cell destruction in T1DM. Through the JDRF nPOD program, histological examinations of pancreatic tissues from deceased donors can be viewed online.
In T1DM, autoimmune responses are modulated by a delicate balance between pathogenic and regulatory T lymphocytes. While the role of autoimmunity and autoantibody development in the pathogenesis of type 1 diabetes is well-documented, the involvement of cellular immunity is increasingly recognized as a significant factor. Antigen peptides presented by major histocompatibility complexes on APCs trigger effector CD4 + and CD8 + T cell populations necessary for disease initiation. Various types of APCs, including dendritic cells, macrophages, and B cells, can form an immunological synapse containing the T cell receptor, MHC, and cognate autoantigen.
Effector and regulatory T cells target naturally processed epitopes of islet cell autoantigens, controlling autoimmune responses against pancreatic beta cells. Specific epitopes recognized by CD4 + T cells according to HLA class II alleles have been identified. Dendritic cell subsets can process soluble autoantigens and present them to CD4 + T cells. Regulatory T cell populations secrete IL-10 and induce anergy and apoptosis in activated effector T cells. Clinical trials using humanized anti-CD3 monoclonal antibodies have shown promise in enhancing metabolic control in newly diagnosed T1DM cases.
The interaction between CD40 and CD40 ligand in a T-dependent immune response is crucial. Abatacept, a treatment that blocks CD28/CD80/86 interactions, has been successful in preserving beta cell function and improving HbA1c in recently diagnosed T1DM patients. NKT cells may also play a role in suppressing autoimmunity and preventing T1DM. B cells are integral to the pathogenesis of T1DM, with studies emphasizing their importance in disease progression through autoantibody production and antigen presentation.
Bregs matured by antigens can maintain tolerance to islet autoantigens by suppressing autoreactive T cell responses. Unique immune phenotypes have been observed in the B cell segment of individuals carrying specific variants. Type 1 diabetes arises due to autoimmune destruction or dysfunction of pancreatic beta cells, necessitating therapies targeting T and B lymphocytes for autoimmune diabetes.
Genome-wide scans have identified over 40 putative loci of statistical importance in T1DM, with the linkage to HLA loci deemed particularly significant. However, while these scans have generated excitement, diligent replication and association studies in diverse populations are required to identify elusive sequence variations influencing genetic susceptibility.
Post-translational modifications (PTM) enhance the immunostimulatory properties in autoimmune conditions like RA and systemic lupus erythematosus (SLE). In T1DM, altered islet neoantigens may intensify T cell immunogenicity due to abnormal glycosylations and oxidative damage to proteins within pancreatic beta cells.
### **Conclusion**
In conclusion, a comprehensive understanding of the genetic, immunological, and environmental factors contributing to the pathogenesis of T1DM is essential for the development of effective prevention and treatment strategies. Research efforts focused on unraveling the intricate mechanisms underlying the disease promise to pave the way for personalized and targeted approaches to managing this autoimmune condition.
Funding for this project was generously provided by the National Institutes of Health, the Michigan Institute for Clinical & Health Research, the Clinical and Translational Science Award program, and the National Institute of Diabetes and Digestive and Kidney Diseases. We would like to express our deep gratitude to the McNair Medical Institute for their invaluable support.
Footnotes
Disclaimer from the Publisher: The PDF document presented here is an unedited manuscript that has been accepted for publication. It will undergo further editing, formatting, and review before its final release. Please be aware that errors may emerge during this process that could impact the content, and all legal disclaimers pertaining to the journal remain in effect.